NEW YORK (GenomeWeb) – Contract research organization Circuit Clinical said today that it has inked a deal to tap into the University of Buffalo's genomics and biorepository resources for its drug-discovery services.
Under the terms of the agreement, Buffalo, NY-based Circuit Clinical will be able to collect, store, and process blood, tissue, and bodily fluids through the UB biorepository for genomic sequencing and microbiome studies in a value-sharing model.
The UB biorepository is located in the Clinical and Translational Science Institute and managed by the New York State Center of Excellence for Bioinformatics & Life Sciences, overseen by executive director Norma Nowak.
"This unique partnership greatly expands Circuit Clinical's capabilities in creating the medical and genomic datasets needed to develop the next generation of American medicines," Circuit Clinical CEO Irfan Khan said in a statement. "The goal of these collections is to help the pharmaceutical industry identify important targets and promising therapies in the years ahead."
Financial terms of the agreement were not disclosed.